RenovoRx to Participate in Canaccord Genuity MedTech Forum
RenovoRx said it will participate in the Canaccord Genuity MedTech Diagnostics and Digital Health & Services Forum.
Related stories
Poundland Files Administration Notice to Seek Rescue
UK retailer Poundland filed an administration notice to buy time for a rescue.
M impact | EQUITY | Oct 29, 2026, 01:59 PM UTC
Merck Raises Annual Profit Forecast After Topping Q3 Results
Merck shares rose after the company raised its annual profit forecast and reported Q3 results that topped expectations.
M impact | EQUITY | Oct 29, 2026, 01:59 PM UTC
Butterfly Network Q3 Loss Narrows, Revenue Rises; 2026 Outlook Raised
Butterfly Network reported a narrower adjusted loss and higher revenue in Q3, and raised its 2026 revenue outlook.
M impact | EQUITY | Oct 29, 2026, 01:58 PM UTC
Angang Steel Reports Q3 Net Loss of 2.0 Billion Yuan
M impact | EQUITY | Oct 29, 2026, 01:58 PM UTC
Proto Labs Shares Fall 7.6% After Q3 Results and Q4 Guidance
Proto Labs shares were down 7.6% in early Thursday trading. The headline reports higher Q3 adjusted earnings and revenue and that Q4 guidance was set.
M impact | EQUITY | Oct 29, 2026, 01:57 PM UTC
Bank of Jordan Q3 Profit Attributable to Shareholders Is 9.8 Million Dinars
M impact | EQUITY | Oct 29, 2026, 01:57 PM UTC